Microba Life Sciences executed a research agreement with International N&H Denmark, a wholly-owned subsidiary of IFF, as part of the second stage of their ongoing research project.

IFF, a player in the food, beverage, bioscience, and health sectors, selected project species in stage 1 under the initial agreement.

In stage 2, the goal is to isolate and characterise strains from the selected project species.

The research agreement, anticipated to end in October 2024, grants IFF an exclusive option for licensing and commercialisation.